FREE Case Review (866) 588-0600

AndroGel Lawsuit Filed in Indiana

An Indiana woman whose husband allegedly died from a heart attack after using AndroGel has filed a product liability lawsuit against AbbVie Inc. and Abbott Laboratories.

An Indiana woman whose husband allegedly died from a heart attack after using AndroGel has filed a product liability lawsuit against AbbVie Inc. and Abbott Laboratories.

Free Confidential Lawsuit Evaluation: If you or a loved one was injured by AndroGel side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the Problem?

March 30, 2016 – According to the lawsuit, which was filed January 20 in the U.S. District Court for the District of Pennsylvania, the deceased was about 55 years old when his doctor prescribed him AndroGel for hypogonadism – a medical condition that causes low testosterone (“Low T”) levels.

Plaintiff alleges that neither her husband nor his physician were aware of the risks associated with AndroGel — heart attack, stroke, blood clots and pulmonary embolism — because the manufacturers failed to adequately warn about these risks. As a result, the deceased could not have been aware “of the true risks associated with the use of AndroGel,” according to the lawsuit.

Unfortunately, about 4 years later, on Jan. 20, 2014, the man had a fatal heart attack. Plaintiff claims AndroGel was the cause of death, stating that it resulted in significant pain and suffering, financial loss, and permanent injury both to herself and her husband.

Plaintiff further contends that AbbVie and Abbott launched a massive marketing campaign in which they suggested that common symptoms of aging and lifestyle choices — increased body fat, moodiness and listlessness — were actually caused by low testosterone, and that men should talk to their doctors about the benefits of AndroGel.

As a result of this aggressive marketing campaign, sales of testosterone boosters have more than doubled since 2006, with forecasts indicating a potential tripling by next year. However, a number of studies have linked these supplements to an increased risk of heart attack and stroke, including one in 2010 that was stopped early because a large number of men suffered adverse events after using the products.

In 2013, a study found that testosterone replacement therapy (TRT) increased the risk of cardiovascular events by approximately 30%, and another study published the next year determined that testosterone use doubled the risk of heart attack in men over the age of 65, and in younger men who had a pre-existing history of heart disease.

AbbVie and Abbott failed to add new warnings to the labeling of AndroGel despite the studies’ findings, leaving unsuspecting men at risk for serious injury and death, according to the lawsuit. Plaintiff is alleging inadequate warnings, fraud, violation of Indiana’s consumer sales act and wrongful death. She seeks both compensatory and punitive damages in excess of $150,000.

Do I Have an AndroGel Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in AndroGel lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

Free Confidential Case Evaluation: Again, if you suffered a heart attack, stroke, blood clot or other serious side effects after using AndroGel, you should contact our law firm immediately. You may be entitled to a settlement by filing a lawsuit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*

Awards & recognition